LIRAGLUTIDE - Food and Drug Administration

Set ID
d8dac6c8-0045-42cf-b357-c3350b4ada5c
Type
Indexing - product concept
Effective date
2025-10-21
Version
2
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameLupin Pharmaceuticals, Inc. | LUPIN LIMITED2026-10-30
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameOrbicular Pharmaceutical Technologies Private Limited | Gland Pharma Limited2026-10-15
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameOrbicular Pharmaceutical Technologies Private Limited | Gland Pharma Limited2026-10-15
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameCipla USA Inc. | GLAND PHARMA LIMITED2026-10-09
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameMeitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.2026-07-27
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameNorthStar Rx LLC | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.2026-06-24
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameCipla USA Inc. | GLAND PHARMA LIMITED2026-06-18
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameHikma Pharmaceuticals USA Inc.2026-05-14
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameOrbicular Pharmaceutical Technologies Private Limited | Gland Pharma Limited2026-04-16
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameHikma Pharmaceuticals USA Inc.2026-03-30
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameOrbicular Pharmaceutical Technologies Private Limited | Gland Pharma Limited2026-03-16
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameOrbicular Pharmaceutical Technologies Private Limited | Gland Pharma Limited2026-03-12
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameTeva Pharmaceuticals, Inc.2026-02-27
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameTeva Pharmaceuticals, Inc.2026-02-27
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameCipla USA Inc. | GLAND PHARMA LIMITED2026-02-25
These highlights do not include all the information needed to use SAXENDA ® safely and effectively. See full prescribing information for SAXENDA. SAXENDA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameNovo Nordisk Pharmaceutical Industries, LP2026-02-25
These highlights do not include all the information needed to use SAXENDA ® safely and effectively. See full prescribing information for SAXENDA. SAXENDA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameNovo Nordisk2026-02-25
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameNorthStar Rx LLC | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.2026-02-16
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION . LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameTeva Pharmaceuticals USA, Inc.2026-01-30
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameMeitheal Pharmaceuticals Inc. | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.2026-01-30
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameTeva Pharmaceuticals, Inc.2026-01-30
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameCipla USA Inc. | GLAND PHARMA LIMITED2026-01-12
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameLupin Pharmaceuticals, Inc. | LUPIN LIMITED2025-11-13
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameBiocon Pharma Inc. | Biocon Pharma Limited | Biocon Biologics Limited2025-10-16
These highlights do not include all the information needed to use SAXENDA ® safely and effectively. See full prescribing information for SAXENDA. SAXENDA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameNovo Nordisk2025-10-14
These highlights do not include all the information needed to use VICTOZA ® safely and effectively. See full prescribing information for VICTOZA. VICTOZA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameNovo Nordisk2025-10-14
These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6 . XULTOPHY ® 100/3.6 (insulin degludec and liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2016Product nameNovo Nordisk2025-10-14
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameBiocon Pharma Inc. | Biocon Pharma Limited | Biocon Biologics Limited2025-10-10
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameLupin Pharmaceuticals, Inc. | LUPIN LIMITED2025-09-11
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION. LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameTeva Pharmaceuticals, Inc.2025-05-30
These highlights do not include all the information needed to use SAXENDA ® safely and effectively. See full prescribing information for SAXENDA. SAXENDA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameNovo Nordisk | Novo Nordisk A/S - Hax | Novo Nordisk Pharmaceutical Industries, LP | Novo Nordisk A/S | Novo Nordisk A/S - 25a-B2025-05-01
These highlights do not include all the information needed to use VICTOZA ® safely and effectively. See full prescribing information for VICTOZA. VICTOZA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameNovo Nordisk | Novo Nordisk A/S | Novo Nordisk Pharmaceutical Industries, LP2025-05-01
These highlights do not include all the information needed to use XULTOPHY ® 100/3.6 safely and effectively. See full prescribing information for XULTOPHY 100/3.6 . XULTOPHY 100/3.6 (insulin degludec and liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2016Product nameNovo Nordisk2025-05-01
These highlights do not include all the information needed to use LIRAGLUTIDE INJECTION safely and effectively. See full prescribing information for LIRAGLUTIDE INJECTION . LIRAGLUTIDE injection, for subcutaneous use Initial U.S. Approval: 2010Product nameA-S Medication Solutions2025-01-30
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) human prescription drug labelProduct nameHybio Pharmaceutical Co., Ltd. (Pingshan Factory)2024-12-03
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) human prescription drug labelProduct nameHybio Pharmaceutical Co., Ltd. (Pingshan Factory)2024-12-02
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) human prescription drug labelProduct nameHybio Pharmaceutical Co., Ltd. (Pingshan Factory)2024-06-05
These highlights do not include all the information needed to use SAXENDA ® safely and effectively. See full prescribing information for SAXENDA. SAXENDA (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameA-S Medication Solutions2024-01-26
These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA. VICTOZA ® (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameA-S Medication Solutions2023-02-06
These highlights do not include all the information needed to use VICTOZA safely and effectively. See full prescribing information for VICTOZA. VICTOZA ® (liraglutide) injection, for subcutaneous use Initial U.S. Approval: 2010Product nameA-S Medication Solutions2023-02-06